• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】10038

【品名】4-Methoxyphenylacetone; 1-(4-Methoxyphenyl)acetone

【CA登记号】122-84-9

【 分 子 式 】C10H12O2

【 分 子 量 】164.20408

【元素组成】C 73.15% H 7.37% O 19.49%

与该中间体有关的原料药合成路线共 9 条

合成路线1

该中间体在本合成路线中的序号:(I)

A new synthesis of YM-12617-1, the active R-isomer of YM-12617, has been described: The reductocondensation of 1-(4-methoxyphenyl)-2-propanone (I) with R-1-phenylethylamine (II) gives regioselectively the secondary amine (III) as the HCl salt, which by sulfonation with chlorosulfonic acid and treatment with NH4OH yields (R,R)-2-methoxy-5-[2-(1-phenylethylamino)propyl]benzenesulfonamide (IV). Eliminating the protecting group by hydrogenation, the free amine hydrochloride (V) is obtained, which is finally submitted to a reductocondensation with 2-(2-ethoxyphenoxy)acetaldehyde (VI) by means of sodium borohydride in methanol, and treated with HCl in ether.

1 Hunden, D.C.; Wheller, W.J.; Schmiegel, K.K.; The synthesis of the 14C and 2H-isotopomers of (R)-N-[2-(2'-ethoxyphenoxy)-ethyl]-N-2-[3-(4'-methoxy-3'-sulfonamido)-phenyl]-propylamine hydrochloride, an alpha1-adrenoreceptor antagonist. J Label Compd Radiopharm 1989, 26, 2, 171.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 10038 4-Methoxyphenylacetone; 1-(4-Methoxyphenyl)acetone 122-84-9 C10H12O2 详情 详情
(II) 10039 (1R)-1-Phenylethylamine; (1R)-1-Phenyl-1-ethanamine.; L-alpha-Phenylethylamine 3886-69-9 C8H11N 详情 详情
(III) 10040 (2R)-1-(4-Methoxyphenyl)-N-[(1R)-1-phenylethyl]-2-propanamine; N-[(1R)-2-(4-Methoxyphenyl)-1-methylethyl]-N-[(1R)-1-phenylethyl]amine C18H23NO 详情 详情
(IV) 10041 2-Methoxy-5-((2R)-2-[[(1R)-1-phenylethyl]amino]propyl)benzenesulfonamide C18H24N2O3S 详情 详情
(V) 10042 5-[(2R)-2-Aminopropyl]-2-methoxybenzenesulfonamide 112101-81-2 C10H16N2O3S 详情 详情
(VI) 10043 2-(2-Ethoxyphenoxy)acetaldehyde 103181-55-1 C10H12O3 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

The demethylation of 1-(4-methoxyphenyl)acetone (I) by means of AlCl3 gives the corresponding 4-hydroxy compound (III), which is condensed with epichlorohydrin (III), yielding the expected oxiranylmethyl ether (IV). The addition of 1-(2-methoxyphenyl)piperazine (V) to the epoxide ring of (IV) affords the isopropyl alcohol derivative (VI), which is condensed with dimethylformamide dimethylacetal (VII) to afford the dimethylaminobutenone (VIII). Finally, this compound is cyclized with 2-cyanoacetamide (IX) by means of sodium ethoxide, providing the target pyridone.

1 (Beiersdorf-Lilly GmbH); Phenylpiperazinylpropanol derivs.. DE 3424685; EP 0167121; ES 8608511; JP 1986030573; US 4631279; US 4631281 .
2 Armah, B.I.; Stenzel, W.; SATERINONE (BDF 8634): A DIFFERENT CONCEPT FOR PHARMACOTHERAPY OF CONGESTIVE HEART FAILURE. Drugs Fut 1989, 14, 5, 445.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 10038 4-Methoxyphenylacetone; 1-(4-Methoxyphenyl)acetone 122-84-9 C10H12O2 详情 详情
(II) 43654 1-(4-hydroxyphenyl)acetone C9H10O2 详情 详情
(III) 10146 Epichlorohydrin; 2-(Chloromethyl)oxirane 106-89-8 C3H5ClO 详情 详情
(IV) 43655 1-[4-(2-oxiranylmethoxy)phenyl]acetone C12H14O3 详情 详情
(V) 11882 1-(2-Methoxyphenyl)piperazine; Methyl 2-piperazinophenyl ether; 1-(2-Methoxyphenyl)-piperazine 35386-24-4 C11H16N2O 详情 详情
(VI) 43656 1-(4-[2-hydroxy-3-[4-(2-methoxyphenyl)-1-piperazinyl]propoxy]phenyl)acetone C23H30N2O4 详情 详情
(VII) 11984 N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal 4637-24-5 C5H13NO2 详情 详情
(VIII) 43657 (Z)-4-(dimethylamino)-3-(4-[2-hydroxy-3-[4-(2-methoxyphenyl)-1-piperazinyl]propoxy]phenyl)-3-buten-2-one C26H35N3O4 详情 详情
(IX) 12122 Cyanoacetamide; 2-Cyanoacetamide 107-91-5 C3H4N2O 详情 详情

合成路线3

该中间体在本合成路线中的序号:(IX)

By reduction of a mixture of 1-(3-formylamino-4-hydroxyphenyl)-2-aminoethanol (VIII) and 1-(4-methoxyphenyl)-2-propanone (IX) with H2 over Pt in ethanol, followed by a treatment with fumaric acid (A).

1 Tanoury GJ, Hett R,Kessler D,et aL 2002. Taking advantage of polymorphism to effect an impurity removalt: development of a thermodynamic crystal form of (R,R)-fonnoterol tartnte. Org Proc Res Dev,6 (6).855~862
1 Murase, K.; et al.; JP 7512040 .
2 Castaner, J.; Weetman, D.F.; BD 40A. Drugs Fut 1977, 2, 10, 639.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 23808 Fumaric acid; (E)-2-butenedioic acid 110-17-8 C4H4O4 详情 详情
(I) 66381 (1R,2S)-1-Amino-2-indanol 7480-35-5 C9H11NO 详情 详情
(II) 32764 (3aR,8aS)-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d][1,3,2]oxazaborole C9H10BNO 详情 详情
(III) 32765 (1R)-1-[4-(benzyloxy)-3-nitrophenyl]-2-bromo-1-ethanol 188690-82-6 C15H14BrNO4 详情 详情
(IV) 32766 (1R)-1-[3-amino-4-(benzyloxy)phenyl]-2-bromo-1-ethanol C15H16BrNO2 详情 详情
(V) 32767 2-(benzyloxy)-5-[(1R)-2-bromo-1-hydroxyethyl]phenylformamide C16H16BrNO3 详情 详情
(VI) 32738 tert-butyl (2S,3S)-2-[(2-[[2-([[(1S,2S)-1-(tert-butoxycarbonyl)-2-methylbutyl]amino]carbonyl)phenyl]disulfanyl]benzoyl)amino]-3-methylpentanoate C34H48N2O6S2 详情 详情
(VII) 32769 5-((1R)-2-[benzyl[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]-1-hydroxyethyl)-2-(benzyloxy)phenylformamide C33H36N2O4 详情 详情
(VIII) 33905 5-[(1R)-2-amino-1-hydroxyethyl]-2-hydroxyphenylformamide C9H12N2O3 详情 详情
(VIII) 66382 N-[2-Hydroxy-5-[1(R)-hydroxy-2-[2-(4-methoxyphenyl)-1(R)-methylethylamino]ethyl]phenyl]formamide 67346-49-0 C19H24N2O4 详情 详情
(IX) 10038 4-Methoxyphenylacetone; 1-(4-Methoxyphenyl)acetone 122-84-9 C10H12O2 详情 详情

合成路线4

该中间体在本合成路线中的序号:(IX)

The enantioselective reduction of phenacyl bromide (I) with BH3.S(CH3)2 in THF catalyzed by the chiral borolidine (II) (obtained by reaction of (1R,2S)-1-amino-2-indanol (III) with BH3.S(CH3)2 in THF) gives the (R)-2-bromo-1-(4-benzyloxy-3-nitrophenyl)ethanol (IV), which is reduced with H2 over PtO2 in THF/toluene yielding the corresponding amino derivative (V). The reaction of (V) with formic acid and Ac2O affords the formamide (VI), which is condensed with the chiral (R)-N-benzyl-N-[2-(4-methoxyphenyl)-1-methylethyl]amine (VII) in THF/methanol providing the protected target compound (VIII). Finally, this compound is debenzylated by hydrogenation with H2 over Pd/C in ethanol. The intermediate the chiral (R)-N-benzyl-N-[2-(4-methoxyphenyl)-1-methylethyl]amine (VII) has been obtained by reductocondensation of 1-(4-methoxyphenyl)-2-propanone (IX) and benzylamine by hydrogenation with H2 over Pd/C in methanol yielding racemic N-benzyl-N-[2-(4-methoxyphenyl)-1-methylethyl]amine (X), which is submitted to optical resolution with (S)-mandelic acid to obtain the desired (R)-enantiomer (VII).

1 Hett, R.; et al.; Large-scale synthesis of enantio- and diastereomerically pure (R,R)-formoterol. Org Process Res Dev 1998, 2, 2, 96.
2 Hett, R.; Senanayake, C.H.; Fang, K.Q.; Wald, S.A.; Redmon, M.P.; Gao, Y. (Sepracor Inc.); Formoterol process. US 6040344 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
15147 Benzylamine; Phenylmethanamine 100-46-9 C7H9N 详情 详情
(I) 32763 1-[4-(benzyloxy)-3-nitrophenyl]-2-bromo-1-ethanone C15H12BrNO4 详情 详情
(II) 32764 (3aR,8aS)-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d][1,3,2]oxazaborole C9H10BNO 详情 详情
(III) 27559 (1R,2S)-1-amino-2,3-dihydro-1H-inden-2-ol C9H11NO 详情 详情
(IV) 32765 (1R)-1-[4-(benzyloxy)-3-nitrophenyl]-2-bromo-1-ethanol 188690-82-6 C15H14BrNO4 详情 详情
(V) 32766 (1R)-1-[3-amino-4-(benzyloxy)phenyl]-2-bromo-1-ethanol C15H16BrNO2 详情 详情
(VI) 32767 2-(benzyloxy)-5-[(1R)-2-bromo-1-hydroxyethyl]phenylformamide C16H16BrNO3 详情 详情
(VII) 32738 tert-butyl (2S,3S)-2-[(2-[[2-([[(1S,2S)-1-(tert-butoxycarbonyl)-2-methylbutyl]amino]carbonyl)phenyl]disulfanyl]benzoyl)amino]-3-methylpentanoate C34H48N2O6S2 详情 详情
(VIII) 32769 5-((1R)-2-[benzyl[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]-1-hydroxyethyl)-2-(benzyloxy)phenylformamide C33H36N2O4 详情 详情
(IX) 10038 4-Methoxyphenylacetone; 1-(4-Methoxyphenyl)acetone 122-84-9 C10H12O2 详情 详情
(X) 32770 N-benzyl-N-[2-(4-methoxyphenyl)-1-methylethyl]amine; N-benzyl-1-(4-methoxyphenyl)-2-propanamine C17H21NO 详情 详情

合成路线5

该中间体在本合成路线中的序号:(I)

The intermediate N-benzyl-N-[1(R)-methyl-2-(4-methoxyphenyl)ethyl]amine (IV) has been obtained as follows: The reductocondensation of 1-(4-methoxyphenyl)-2-propanone (I) with benzylamine (II) by H2 over Pd/C gives the N-benzyl-N-[1-methyl-2-(4-methoxyphenyl)ethyl]amine (III) as a racemic mixture, which is submitted to optical resolution with L-mandelic acid in methanol to obtain the desired (R)-enantiomer (IV). The reaction of cis-(1R,2S)-1-aminoindan-2-ol (V) with trimethylboroxine in toluene gives the (1R,2S)-oxazaborolidine (VI), which is used as chiral catalyst in the enantioselective reduction of 4-benzyloxy-3-nitrophenacyl bromide (VII) by means of BH3/THF, yielding the chiral bromoethanol derivative (VIII). The reaction of (VIII) with NaOH in aqueous methanol affords the epoxide (IX), which is condensed with the intermediate amine (IV) by heating the mixture at 90 C to provide the adduct (X). The reduction of the nitro group of (X) with H2 over PtO2 gives the corresponding amino derivative (XI), which is acylated with formic acid to afford the formamide compound (XII). Finally, this compound is debenzylated by hydrogenation with H2 over Pd/C in ethanol, providing the target compound.

1 Wilkinson, H.S.; et al.; Modulation of catalyst reactivity for the chemoselective hydrogenation of functionalized nitroarene: Preparation of a key intermediate in the synthesis of (R,R)-formoterol tartrate. Org Process Res Dev 2000, 4, 6, 567.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 10038 4-Methoxyphenylacetone; 1-(4-Methoxyphenyl)acetone 122-84-9 C10H12O2 详情 详情
(II) 15147 Benzylamine; Phenylmethanamine 100-46-9 C7H9N 详情 详情
(III) 32770 N-benzyl-N-[2-(4-methoxyphenyl)-1-methylethyl]amine; N-benzyl-1-(4-methoxyphenyl)-2-propanamine C17H21NO 详情 详情
(IV) 32768 (2R)-N-benzyl-1-(4-methoxyphenyl)-2-propanamine; N-benzyl-N-[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amine C17H21NO 详情 详情
(V) 27559 (1R,2S)-1-amino-2,3-dihydro-1H-inden-2-ol C9H11NO 详情 详情
(VI) 34898 (3aR,8aS)-2-methyl-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d][1,3,2]oxazaborole C10H12BNO 详情 详情
(VII) 32763 1-[4-(benzyloxy)-3-nitrophenyl]-2-bromo-1-ethanone C15H12BrNO4 详情 详情
(VIII) 32765 (1R)-1-[4-(benzyloxy)-3-nitrophenyl]-2-bromo-1-ethanol 188690-82-6 C15H14BrNO4 详情 详情
(IX) 50312 (2R)-2-[4-(benzyloxy)-3-nitrophenyl]oxirane; benzyl 2-nitro-4-[(2R)oxiranyl]phenyl ether C15H13NO4 详情 详情
(X) 50313 (1R)-2-[benzyl[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]-1-[4-(benzyloxy)-3-nitrophenyl]-1-ethanol C32H34N2O5 详情 详情
(XI) 50314 (1R)-1-[3-amino-4-(benzyloxy)phenyl]-2-[benzyl[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]-1-ethanol C32H36N2O3 详情 详情
(XII) 32769 5-((1R)-2-[benzyl[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]-1-hydroxyethyl)-2-(benzyloxy)phenylformamide C33H36N2O4 详情 详情

合成路线6

该中间体在本合成路线中的序号:(I)

Thiophene (III) was obtained by condensation of (4-methoxyphenyl)acetone (I) with ethyl cyanoacetate (II) in the presence of NH4OAc and AcOH, followed by treatment with sulfur and diethylamine. Subsequent reaction of (III) with ethyl isocyanato-acetate (IV) in pyridine at 45 C and further cyclization with ethanolic NaOEt provided the thienopyrimidine (V). Cleavage of the methyl ether was performed by treatment with AlCl3 and dimethyl disulfide in CH2Cl2 at r.t. to afford phenol (VI), which was then acetylated with Ac2O in pyridine to give ester (VII). N-Alkylation with 2-(methylsulfanyl)benzyl chloride (VIII) in the presence of K2CO3 in DMF yielded (IX), and then the acetate ester was hydrolyzed with K2CO3 in a mixture of H2O/MeOH/THF. The resulting phenol (X) was alkylated with chloromethyl methyl ether (XI) in the presence of NaH to provide (XII).

1 Cho, N.; Nara, Y.; Harada, M.; Sugo, T.; Masuda, Y.; Abe, A.; Kusumoto, K.; Itoh, Y.; Ohtaki, T.; Watanabe, T.; Furuya, S.; Thieno[2,3-d]pyrimidine-3-acetic acids a new class of nonpeptide endothelin receptor antagonists. Chem Pharm Bull 1998, 46, 11, 1724.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 10038 4-Methoxyphenylacetone; 1-(4-Methoxyphenyl)acetone 122-84-9 C10H12O2 详情 详情
(II) 11877 Cyanoacetic acid ethyl ester; Ethyl 2-cyanoacetate; Ethyl cyanoacetate; Ethyl isocyanacetate 105-56-6 C5H7NO2 详情 详情
(III) 18311 ethyl 2-amino-5-(4-methoxyphenyl)-4-methyl-3-thiophenecarboxylate C15H17NO3S 详情 详情
(IV) 18312 ETHYL ISOCYANATOACETATE; ethyl 2-isocyanatoacetate 2949-22-6 C5H7NO3 详情 详情
(V) 18313 ethyl 2-[6-(4-methoxyphenyl)-5-methyl-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl]acetate C18H18N2O5S 详情 详情
(VI) 18314 ethyl 2-[6-(4-hydroxyphenyl)-5-methyl-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl]acetate C17H16N2O5S 详情 详情
(VII) 18315 ethyl 2-[6-[4-(acetoxy)phenyl]-5-methyl-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl]acetate C19H18N2O6S 详情 详情
(VIII) 18316 1-(chloromethyl)-2-(methylsulfanyl)benzene; 2-(chloromethyl)phenyl methyl sulfide C8H9ClS 详情 详情
(IX) 18317 ethyl 2-[6-[4-(acetoxy)phenyl]-5-methyl-1-[2-(methylsulfanyl)benzyl]-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl]acetate C27H26N2O6S2 详情 详情
(X) 18318 ethyl 2-[6-(4-hydroxyphenyl)-5-methyl-1-[2-(methylsulfanyl)benzyl]-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl]acetate C25H24N2O5S2 详情 详情
(XI) 18319 Chloro(methoxy)methane; Chloromethyl methyl ether 107-30-2 C2H5ClO 详情 详情
(XII) 18320 ethyl 2-[6-[4-(methoxymethoxy)phenyl]-5-methyl-1-[2-(methylsulfanyl)benzyl]-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl]acetate C27H28N2O6S2 详情 详情

合成路线7

该中间体在本合成路线中的序号:(III)

N-Benzoylisonipecotic acid (I) was chlorinated with SOCl2 to produce the corresponding acid chloride (II). Acylation of the lithium enolate of (4-methoxyphenyl)acetone (III) with acid chloride (II) provided a mixture of diketone regioisomers (IV) and (V); these were separated by column chromatography. The desired diketone (IV) was then cyclized with guanidine (VI) in hot pyridine to afford the pyrimidine (VII). Basic hydrolysis of the benzamide function of (VII) gave the piperidine derivative (VIII). The target amide was finally prepared by acylation of (VIII) with 3,4-methylenedioxybenzoic acid (IX) in the presence of EDC.

1 Kawakami, H.; Kurimoto, A.; Murata, S.; Fujita, H.; Iwai, K.; Fujiwara, N.; Synthesis and bioactivities of novel piperidylpyrimidine derivatives: Inhibitors of tumor necrosis factor-alpha production. Bioorg Med Chem Lett 2000, 10, 12, 1317.
2 Fujiwara, N.; Ueda, Y.; Murata, S.; Hirota, F.; Kawakami, H.; Fujita, H. (Sumitomo Pharmaceuticals Co., Ltd.); Piperidinylpyramidine derivs.. EP 0892795; JP 2001511764; US 5948786; WO 9738992 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 52892 1-benzoyl-4-piperidinecarboxylic acid C13H15NO3 详情 详情
(II) 52893 1-benzoyl-4-piperidinecarbonyl chloride C13H14ClNO2 详情 详情
(III) 10038 4-Methoxyphenylacetone; 1-(4-Methoxyphenyl)acetone 122-84-9 C10H12O2 详情 详情
(IV) 52894 1-(1-benzoyl-4-piperidinyl)-4-(4-methoxyphenyl)-1,3-butanedione C23H25NO4 详情 详情
(V) 52895 1-(1-benzoyl-4-piperidinyl)-2-(4-methoxyphenyl)-1,3-butanedione C23H25NO4 详情 详情
(VI) 14790 Guanidine 113-00-8 CH5N3 详情 详情
(VII) 52896 {4-[2-amino-6-(4-methoxybenzyl)-4-pyrimidinyl]-1-piperidinyl}(phenyl)methanone C24H26N4O2 详情 详情
(VIII) 52897 4-(4-methoxybenzyl)-6-(4-piperidinyl)-2-pyrimidinamine; 4-(4-methoxybenzyl)-6-(4-piperidinyl)-2-pyrimidinylamine C17H22N4O 详情 详情
(IX) 10125 1,3-Benzodioxole-5-carboxylic acid 94-53-1 C8H6O4 详情 详情

合成路线8

该中间体在本合成路线中的序号:(IX)

 

1 Tanoury GJ, Hett R,Kessler D,et aL 2002. Taking advantage of polymorphism to effect an impurity removalt: development of a thermodynamic crystal form of (R,R)-fonnoterol tartnte. Org Proc Res Dev,6 (6).855~862
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VI) 32738 tert-butyl (2S,3S)-2-[(2-[[2-([[(1S,2S)-1-(tert-butoxycarbonyl)-2-methylbutyl]amino]carbonyl)phenyl]disulfanyl]benzoyl)amino]-3-methylpentanoate C34H48N2O6S2 详情 详情
(IX) 10038 4-Methoxyphenylacetone; 1-(4-Methoxyphenyl)acetone 122-84-9 C10H12O2 详情 详情
(X) 32770 N-benzyl-N-[2-(4-methoxyphenyl)-1-methylethyl]amine; N-benzyl-1-(4-methoxyphenyl)-2-propanamine C17H21NO 详情 详情

合成路线9

该中间体在本合成路线中的序号:(XIX)

N-Protection of 4-(2-amino-2-methylpropyl)phenol (XVI) with CbzCl by means of na2Co3 in CH2Cl2/H2o yields the benzyl carbamate (XVII), which is then O-alkylated with MeI using K2Co3 in DMF to give the methyl ether (XVIII). Finally, compound (XVIII) is N-deprotected by means of H2 over Pd/C in MeoH .
In an alternative method, addition of MeMgCl to 1-(4-methoxyphenyl) acetone (XIX) in toluene produces 1-(4-methoxyphenyl)-2-methyl-2-propanol (XX), which then undergoes Ritter reaction with acetonitrile in the presence of H2So4 in AcoH to afford the N-substituted acetamide (XXI) . Finally, amide (XXI) is hydrolyzed with naoH or KoH in ethoxyethanol/ethylene glycol at 150 °C (III) .

1 Bouyssou, T., Hoenke, C., Rudolf, K. et al. Discovery of olodaterol, a novel inhaled b2-adrenoceptor agonist with a 24 h bronchodilatory efficacy. Bioorg Med Chem Lett 2010, 20(4): 1410-4.
2 Krueger, T., Ries, U., Schnaubelt, J., Rall, W., Leuter, Z.A., Duran, A., Soyka, R. (Boehringer Ingelheim Pharma GmbH & Co. KG). Method for producing betamimetics. EP 1917253, JP 2009504708, US 201114859, Wo 2007020227.
3 Rodriguez Dehli, J.M., Hagenkoetter, R., Schul, M., Stange, C. (Boehringer Ingelheim Pharma GmbH & Co. KG). Method for producing betamimetics. EP 2125759, JP 2010516739, US 2010022770, Wo 2008090193.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(III) 68014 2-(4-methoxyphenyl)-1,1-dimethylethylamine   C11H17NO 详情 详情
(XVI) 29476 4-(2-amino-2-methylpropyl)phenol 51706-55-9 C10H15NO 详情 详情
(XVII) 68026 benzyl (1-(4-hydroxyphenyl)-2-methylpropan-2-yl)carbamate   C18H21NO3 详情 详情
(XVIII) 68027 benzyl (1-(4-methoxyphenyl)-2-methylpropan-2-yl)carbamate   C19H23NO3 详情 详情
(XIX) 10038 4-Methoxyphenylacetone; 1-(4-Methoxyphenyl)acetone 122-84-9 C10H12O2 详情 详情
(XX) 68028 1-(4-methoxyphenyl)-2-methylpropan-2-ol   C11H16O2 详情 详情
(XXI) 68029 N-(1-(4-methoxyphenyl)-2-methylpropan-2-yl)acetamide   C13H19NO2 详情 详情
Extended Information